Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)

Summary

The purpose of this study is to determine whether a single intravitreal (into the gel of the eye) injection of Avastin 0.625mg or 0.75mg is equivalent (non-inferior) to treatment with standard of care laser in infants with Type I pre-threshold retinopathy of prematurity (ROP) diagnosed at 30-36 weeks gestational age.

Timeline

Start

2012-06

Primary completion

2015-04

Completion

2018-07

Outcome

Outcome not reported

Stopped (Business): “Lack of funding”

Drugs

Indications